Vivanza Biosciences

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue3.923.392.270.431.58
Expenses3.743.202.530.201.58
EBITDA0.300.28-0.160.320.10
EBIT0.300.28-0.180.320.10
Profit Before Tax0.190.18-0.270.230.01
Net Profit0.190.18-0.380.230.01
Financial Ratios
Operating Profit Margin7.75%8.31%-6.96%74.42%6.33%
Net Profit Margin4.91%5.34%-16.52%53.49%0.63%
Earning Per Share (Diluted)0.050.05-0.090.060.00
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ